The hunt for an HIV vaccine: time to rethink recent failures

The Lancet

Volumn 371, Issue 9628, 2008, Pages 1897-1898

  Boasso, Adriano ^a   Shearer, Gene M ^b   Clerici, Mario ^c  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROTECTION; DISEASE COURSE; DOWN REGULATION; DRUG DESIGN; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; MEDICAL RESEARCH; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 44649126811     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60812-0     Document Type: Note

References (10)

1. Anon. HIV vaccine failure prompts Merck to halt trial. Nature 449 (2007) 390
2. Munier M., and Kelleher A. Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol 85 (2007) 6-15
3. Clerici M., Stocks N., Zajac R., et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 84 (1989) 1892-1899
4. Boasso A., and Shearer G. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab 8 (2007) 217-223
5. Clerici M., and Shearer G. A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14 (1993) 107-111
6. Brenchley J., Price D., and Douek D. HIV disease: fallout from a mucosal catastrophe?. Nat Immunol 7 (2006) 235-239
7. Franchini G., Nacsa J., Hel Z., and Tryniszewska E. Immune intervention strategies for HIV-1 infection of humans in the SIV macaque model. Vaccine 20 suppl 4 (2002) A52-A60
8. Boasso A., and Shearer G. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 126 (2008) 235-242
9. Chirmule N., and Pahwa S. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev 60 (1996) 386-406
10. Herbeuval J., and Shearer G. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?. AIDS Rev 8 (2006) 3-8